95 results
8-K
INM
InMed Pharmaceuticals Inc
20 Mar 24
InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance
1:44pm
Rules. However, if the Company does appeal Nasdaq’s delisting determination to the Hearings Panel, there can be no assurance that such appeal would
8-K
EX-10.1
ru39lj9nrzf ii
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
q5r5vef8ktyk6q
22 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:29pm